Tech Company Financing Transactions
Cytogel Pharma Funding Round
On 3/21/2014, Cytogel Pharma announced $240 thousand in funding from private investors.
Transaction Overview
Company Name
Announced On
3/21/2014
Transaction Type
Debt
Amount
$240,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Thorndal Cir.
Darien, CT 06820
USA
Darien, CT 06820
USA
Phone
Website
Email Address
Overview
Cytogel Pharma is a bio-pharmaceutical development company that pursues strategic opportunities for pharmaceutical product development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dean Maglaris
Chief Scientific Officer
Theodore Maione
VP - Bus. Development
James Hamsher
Browse more venture capital transactions:
Prev: 3/21/2014: Faraday venture capital transaction
Next: 3/21/2014: Evomail venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs